Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches

M Riedl, F Fakhouri, M Le Quintrec… - … in thrombosis and …, 2014 - thieme-connect.com
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.

M Riedl, F Fakhouri, M Le Quintrec… - … in Thrombosis and …, 2014 - europepmc.org
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

[引用][C] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

M Riedl, F Fakhouri, M Le Quintrec… - … in Thrombosis and …, 2014 - hal.umontpellier.fr
Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights
Identifying Novel Treatment Approaches - Université de Montpellier Accéder directement au …

[引用][C] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

M Riedl, F Fakhouri, M Le Quintrec, D Noone… - … in Thrombosis and …, 2014 - hal.science
Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights
Identifying Novel Treatment Approaches - Archive ouverte HAL Accéder directement au contenu …

[PDF][PDF] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

Seminars in Thrombosis & Hemostasis, 2014 - researchgate.net
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches

M Riedl, F Fakhouri, M Le Quintrec… - … in thrombosis and …, 2014 - pubmed.ncbi.nlm.nih.gov
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

[引用][C] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

M Riedl, F Fakhouri, M Le Quintrec, D Noone… - … in Thrombosis and …, 2014 - cir.nii.ac.jp
Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights
Identifying Novel Treatment Approaches | CiNii Research CiNii 国立情報学研究所 学術情報 …

[PDF][PDF] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

Seminars in Thrombosis & Hemostasis, 2014 - academia.edu
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

[PDF][PDF] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

Seminars in Thrombosis & Hemostasis, 2014 - academia.edu
Thrombotic microangiopathy (TMA) is a rare but severe disorder characterized by
endothelial cell activation and thrombus formation. It manifests with the triad of hemolytic …

[引用][C] Spectrum of Complement-Mediated Thrombotic Microangiopathies: Pathogenetic Insights Identifying Novel Treatment Approaches

M Riedl, F Fakhouri, M Le Quintrec, DG Noone… - Seminars in thrombosis …, 2014 - Thieme